

ARK Israel Innovative Technology ETF
$27.94−0.01 (−0.02%)
- 0.49%
- $134M
- −0.5%
- 2.77%
- 0M sh
- $28.44
- low $25.96high $32.76
The ETF.net IZRL Grade
Score 43 out of 100
- 27 of 38
Score 43 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.
Cost
The fund’s net expense ratio, ranked against its category.B55 out of 100Rank 10 of 38Mission
Whether the fund did what it promised, tested against its stated mandate.C41 out of 100Rank 32 of 35Risk
How the fund held up when markets fell: downside volatility, drawdowns and tail loss.D25 out of 100Rank 34 of 37Tradability
How easy the fund is to trade: daily volume, and how far its price strays from net asset value.D28 out of 100Rank 31 of 38Holdings
How concentrated the fund is, and how complete and current its disclosed holdings are.A71 out of 100Rank 8 of 36Durability
Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.D37 out of 100Rank 32 of 38
Our read on IZRL
CARK's odd one out. Instead of Cathie Wood's team picking stocks, IZRL follows a rules-based index of Israeli-incorporated innovators, equally weighted so the small names carry the same load as the household ones.
IZRL seeks to track, before fees and expenses, the ARK Israeli Innovation Index. The index targets exchange-listed Israeli companies whose operations pursue disruptive innovation across genomics, health care, biotechnology, industrials, manufacturing, the Internet, and information technology.
Why people hold it
- Runs on published rules, not conviction calls: it tracks the ARK Israeli Innovation Index, which screens for companies incorporated or domiciled in Israel and listed in the US or Israel.sec.gov
- 0.49% a year, below the typical disruptive-innovation fund and level with peers like TRFM while undercutting FDTX.
- Equal weighting across roughly 80 stocks means no single giant sets the tone, and smaller Israeli tech names get real room in the basket.stockanalysis.comsec.gov
- A pure local read on Israeli innovation, spanning genomics, biotech, manufacturing and information technology, and trading in the US since its 2017 launch.
Worth knowing
- Thinly traded and modest in size, so the gap between bid and ask can be wider than on the big innovation funds.
- One country, one theme. Israeli market moves, shekel swings and regional headlines land on this portfolio with nothing to offset them.
- Income is an afterthought here: distributions arrive once or twice a year, not monthly.
IZRL Holdings
- Stocks
- 66
- 22%
- RSKD
Sectors
- Technology52.3%
- Health Care17.3%
- Communication13.1%
- Financials5.9%
- Consumer Staples4.9%
- Industrials4.6%
- Consumer Discretionary1.8%
Geography
- Israel91.87%
- United States8.13%
Developed 0% · Emerging 100%
IZRL Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | IZRL |
|---|---|
| Year to date | −6.5% |
| 1 month | −2.2% |
| 3 months | −8.7% |
| 1 year | −0.5% |
| 3 years | +19.2% |
| 5 years | −0.3% |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | IZRL |
|---|---|---|
| 2026 YTD | −6.5% | |
| 2025 | +37.0% | |
| 2024 | +15.3% | |
| 2023 | +11.4% | |
| 2022 | −38.6% | |
| 2021 | −3.6% | |
| 2020 | +34.1% |
IZRL in the news
IZRL Dividends
- 2.77%
- $0.78
- $0.78 per share
- Annual
Distribution history
IZRL Risk
- 22.6%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.60
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −52.4%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.91
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
IZRL Cost
- The middle half of Developed Single Country funds
- Median 0.50%
9 of the 38 Developed Single Country funds charge less.
Other funds in Developed Single Country
- CEISiShares MSCI Israel ETFExpense ratio 0.59%1 year return +19.4%
- CFSZFirst Trust Switzerland AlphaDEX FundExpense ratio 0.80%1 year return +4.4%
- CNORWGlobal X - MSCI Norway ETFExpense ratio 0.50%1 year return +32.5%
- CEWYiShares MSCI South Korea ETFExpense ratio 0.59%1 year return +115.5%
- CISRAVanEck Israel ETFExpense ratio 0.59%1 year return +22.6%




